AevisBio entered into a collaborative research with KRISS

관리자 │ 2023-01-17



In June of 2020, AevisBio and Korea Research Institute of Standards and Science (KRISS) announced a collaboration to develop technologies for treating infectious disease especially focused on COVID19. 

Previous Post Awarded two post-TIPS grants (₩1B each) from Ministry of SMEs and Startups (Ko...
Next Post Korean Government grant awarded from NRF